PatientsVisitorsLocations & ServicesAbout the RegionJoin Our TeamPhysicians
Find:  Locations | Services
Pathology and Laboratory Medicine HomeTest and Services CatalogueTransfusion Medicine Product CataloguePolicy and ProcedureJob AidsSpecimen Collection and TransportRequisitionsAntibiogramsGenetic Testing and Molecular GeneticsMicrobiology EssentialsTransfusion EssentialsReference RangesLaboratory SuppliesAcute Care SCM GuidelinesContact InformationPhysician Access to Patient ResultsNew Clinic or Provider Information Changes
Pathology and Laboratory Medicine
Product Catalogue

​Cellular Therapy Product

Transfusion Medicine

​Alternate Product Names
  • ​Hematopoietic Progenitor cells (HPC)
  • Donor lymphocyte infusion (DLI)
  • Mononuclear Cells (MNC)
  • Stem cells
  • Chimeric Antigen Receptor T Cells (CAR-T Cells)
  • Immune Effector Cells
  • ​Autologous or allogeneic stem cell transplant
  • CAR-T/Immune Effector Cells
    • Treatment of relapsed or refractory hematologic malignancies, including multiple myeloma
  • DLI Infusion
    • Loss of chimerism or relapse post allogeneic transplant in the absence of active or previous GVHD
​Resource Information
  • See Cellular Therapy Processing Facility package insert
Pretransfusion Testing Requirements
  • ​Allogeneic transplants only: group and screen ≤ 96 hours prior to infusion
Forms Required


  • Consultation with the Saskatchewan Blood and Marrow Transplant Program is required
  • ​Refer to Saskatchewan Provincial Blood and Marrow Transplant procedure for Infusion of Hematopoietic Progenitor cells (HPC’s)


​If you choose to print this information, it is valid only on date of print.

Laboratory Controlled Document LSM-51 v2

Last Modified: Wednesday, August 12, 2020 |
Questions or feedback about this page?